Search results
Kenyan doctor spreads harmful disinformation about the WHO, vaccines and infertility
AFP via Yahoo News· 1 hour agoKenyan doctor Wahome Ngare claimed several vaccines were “unnecessary” because they were designed to...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 18 hours agoThat compares to 55.6% for Keytruda alone. Earlier in the year, one analyst called results from the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 18 hours agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Washington conducted secret global anti-vaccine disinformation campaign against China
World Socialist Web Site· 4 days agoAn investigative report published by Reuters on June 14 revealed that the Pentagon conducted a...
12 recent scientific breakthroughs
The Week via Yahoo News· 3 days ago"And, if we do find signs of life elsewhere, we can tell if life on Earth and other planets derived from a common or different origin." 9. Inverse ...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 15 hours agoFood and Drug Administration (FDA) seeking approval of TREMFYA® (guselkumab) for the treatment of adults with moderately to severely active Crohn's disease. The submission ...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
Motley Fool via Yahoo Finance· 6 days agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...
3 Short-Squeeze Stocks Outwitting the Pessimistic Predictions
InvestorPlace· 1 day agoA short-squeeze stocks to buy are something investors need to watch out for. If investors believe...
Why this Wistar scientist sees hope for an HIV cure - Philadelphia Business Journal
The Business Journals· 4 days agoDr. Luis J. Montaner leads the HIV Research Program at The Wistar Institute’s Vaccine &...